Literature DB >> 1996893

Increased incidence of respiratory distress syndrome in babies of hypertensive mothers.

T R Tubman1, M D Rollins, C Patterson, H L Halliday.   

Abstract

There is controversy over the effect of hypertension in pregnancy on the incidence of neonatal respiratory distress syndrome. We investigated the association between maternal hypertension and the incidence of respiratory distress syndrome in 268 very low birthweight babies of less than 34 weeks' gestation. A lower incidence of respiratory distress syndrome was associated with growth retardation and membrane rupture greater than 24 hours. Maternal hypertension was associated with an increased incidence of respiratory distress syndrome. We used the multiple logistic regression model to control for confounding variables, as the maternal and neonatal factors associated with respiratory distress syndrome were not evenly distributed between the two groups. After adjustment for birth weight, gestational age, growth retardation, and membrane rupture greater than 24 hours, the risk of developing respiratory distress syndrome was significantly greater in babies of hypertensive mothers. Significance was lost when labour before delivery and mode of delivery were taken into account. The increased incidence of respiratory distress syndrome in babies of hypertensive mothers may be due to the absence of labour before delivery because of the greater likelihood of caesarean section.

Entities:  

Mesh:

Year:  1991        PMID: 1996893      PMCID: PMC1590360          DOI: 10.1136/adc.66.1_spec_no.52

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP).

Authors:  A Giedion; H Haefliger; P Dangel
Journal:  Pediatr Radiol       Date:  1973-10

2.  Respiratory-distress syndrome.

Authors: 
Journal:  Lancet       Date:  1973-05-12       Impact factor: 79.321

3.  Lecithin-sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy.

Authors:  L Gluck; M V Kulovich
Journal:  Am J Obstet Gynecol       Date:  1973-02-15       Impact factor: 8.661

4.  Prolonged rupture of membranes, pre-eclamptic toxaemia, and respiratory distress syndrome.

Authors:  M L Chiswick
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

5.  The relationship between maternal hypertensive disease of pregnancy and the incidence of idiopathic respiratory distress syndrome.

Authors:  J J Yoon; S Kohl; R G Harper
Journal:  Pediatrics       Date:  1980-04       Impact factor: 7.124

6.  Chronic fetal stress and the risk of infant respiratory distress syndrome.

Authors:  E White; K K Shy; T J Benedetti
Journal:  Obstet Gynecol       Date:  1986-01       Impact factor: 7.661

7.  Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study.

Authors:  O Hjalmarson
Journal:  Acta Paediatr Scand       Date:  1981-11

8.  Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy.

Authors:  J E Brazy; J K Grimm; V A Little
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

9.  Increased incidence of respiratory distress syndrome in infants following pregnancies complicated by hypertension.

Authors:  J R Bowen; G I Leslie; J D Arnold; M P Jones; E D Gallery
Journal:  Aust N Z J Obstet Gynaecol       Date:  1988-05       Impact factor: 2.100

  9 in total
  6 in total

1.  Does smoking in pregnancy modify the impact of antenatal steroids on neonatal respiratory distress syndrome? Results of the Epipage study.

Authors:  A Burguet; M Kaminski; P Truffert; A Menget; L Marpeau; M Voyer; J C Roze; B Escande; G Cambonie; J M Hascoet; H Grandjean; G Breart; B Larroque
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.

Authors:  H M Bryson; R Whittington
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

3.  Maternal hypertension and neurodevelopmental outcome in very preterm infants.

Authors:  P H Gray; M J O'Callaghan; H A Mohay; Y R Burns; J F King
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

4.  Bronchopulmonary dysplasia in infants with respiratory distress syndrome in a developing country: a prospective single centre-based study.

Authors:  J Smith; S Kling; R P Gie; J van Zyl; G F Kirsten; E D Nel; J W Schneider
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

5.  Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates.

Authors:  Alice Wang; Alexander M Holston; Kai F Yu; Jun Zhang; Mourad Toporsian; S Ananth Karumanchi; Richard J Levine
Journal:  J Matern Fetal Neonatal Med       Date:  2011-12-13

6.  Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study.

Authors:  Ting-An Yen; Hwai-I Yang; Wu-Shiun Hsieh; Hung-Chieh Chou; Chien-Yi Chen; Kuo-Inn Tsou; Po-Nien Tsao
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.